67 related articles for article (PubMed ID: 1546303)
1. Alzheimer's assault.
Science; 1992 Feb; 255(5048):1059. PubMed ID: 1546303
[No Abstract] [Full Text] [Related]
2. Alzheimer's disease. Short precursor shortens memory.
Mattson MP; Furukawa K
Nature; 1997 May; 387(6632):457-8. PubMed ID: 9168104
[No Abstract] [Full Text] [Related]
3. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
5. Modeling Alzheimer's disease in transgenic mice.
Duff K
J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
[TBL] [Abstract][Full Text] [Related]
6. Model mice. Transgenic animals and Alzheimer's research.
Erickson D
Sci Am; 1991 Sep; 265(3):34. PubMed ID: 1925493
[No Abstract] [Full Text] [Related]
7. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
LaFerla FM; Oddo S
Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
[TBL] [Abstract][Full Text] [Related]
9. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
Santiard-Baron D; Aupetit J; Janel N
Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
[TBL] [Abstract][Full Text] [Related]
10. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F
Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse models of Alzheimer's disease: phenotype and application.
Higgins GA; Jacobsen H
Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mouse and chemical lesion approaches to the study of Alzheimer's disease.
Tang F; Li H; Nag S; Xu G; Chan T
Chin Med J (Engl); 1997 Aug; 110(8):642-7. PubMed ID: 9594272
[No Abstract] [Full Text] [Related]
13. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
[TBL] [Abstract][Full Text] [Related]
14. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
[TBL] [Abstract][Full Text] [Related]
15. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
[TBL] [Abstract][Full Text] [Related]
16. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
17. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?
Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL
Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166
[No Abstract] [Full Text] [Related]
18. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models.
Brendza RP; Bales KR; Paul SM; Holtzman DM
Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304
[No Abstract] [Full Text] [Related]
19. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
[TBL] [Abstract][Full Text] [Related]
20. Steps towards a mouse model of Alzheimer's disease.
Crowther RA
Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
